SYD FUND

Sinopharm International Investment Co., Ltd ("SIIC"), based on Hong Kong, is the Manager of the Fund. It has a Cayman and WOFE(Chinese) subsidiary. Sinopharm Group, the largest pharmaceutical group in China, and A large Chinese insurance group, are co-founders and have significant equity stakes in SIIC.Core management team has extensive experience in healthcare investment, PE/VC investment, cross-bordered M&A and PIPE.

Primary location: Hangzhou China